Welcome to Supply-Chain360, your all-in-one source for actual insights into the world of SCM!

In this episode, I follow up on Davos 2026 by shifting from speeches and symbolism to the physical realities of global supply chains. The focus is on chokepoints: the Red Sea, Suez, Hormuz, and Taiwan, and on what happens when great-power politics starts to narrow the corridors, systems, and dependencies that modern industries rely on. I look at how recent developments have moved from rhetoric int...

In this episode, I look at Davos 2026 not as a media show, but as a live stress test of the global order. From Merz’ “age of great powers” narrative to Trump’s tariff threats, Greenland remarks, and pressure over U.S. bonds, Davos made one thing clear: the world is being run more openly as a great-power game again, and middle powers, especially in Europe, are caught in the squeeze. I translate thi...

In this episode, I move beyond “one crisis at a time” and look at geopolitics through the lens of a risk portfolio for pharma and med-tech supply chains. Starting from recent events like Venezuela, the Red Sea, Taiwan, and Europe’s energy debate, I sketch a simple way to map exposure versus geopolitical fragility – not as a theoretical exercise, but as a practical tool for network and governance d...

In this episode, I unpack the recent U.S. military operation that led to Nicolás Maduro’s capture and ongoing narco-terrorism proceedings in New York, and look at what this actually means for health and pharma supply chains in and around Venezuela. Rather than debating the politics, I focus on access to medicines, sanctions and logistics friction, and two working scenarios: a managed transition wi...

This short holiday episode is a quick thank-you from me to you before I step away for a year-end break. I share a few reflections on this past year in pharma supply chains and what’s coming next for the podcast, then hit pause until the new year. Wishing you a Merry Christmas, and a healthy start into the new year. See you soon in the next season of Supply Chain 360.

In this episode of Supply Chain 360, we complete the arc from scenarios to signals to action. After building an early-warning radar for your pharma supply chain, the next question is: what happens when a signal actually flashes red? We explore how to turn early warnings into fast, coordinated responses using lean, scenario-specific SOPs – response playbooks. Instead of long policy documents, these...

In this episode of Supply Chain 360, we move one step further along the BANI journey: from imagining possible futures to actually seeing them coming. Building on the previous episode on scenario planning, we explore how pharma organizations can turn scenarios into a practical early-warning system – a simple risk radar that helps you act before disruption fully hits. We look at how to define meanin...

In this episode of Supply Chain 360, we move from forecasting to future-proofing. Instead of asking “What’s the plan?”, we ask a more powerful question: “What if?” We explore how simple, practical scenario planning can help pharma supply chains prepare for the unexpected. From export restrictions and supplier failures to regulatory changes or a sudden surge in demand when a new use for a drug is a...

In this final episode of the BANI mini-series on Supply Chain 360, we shift the focus from systems to the people who run them: leaders. We revisit what it means to operate in a world that is brittle, anxious, nonlinear, and incomprehensible, and explore why supply chains only become truly viable when leadership mindsets evolve. This episode looks at how the best leaders move from control to compos...

In this episode of Supply Chain 360, part of the BANI mini-series, we explore a major shift that isn’t a sudden shock or black-swan event, but a white swan: a visible, predictable transformation that’s already reshaping Europe’s industrial landscape. Recent data shows that around 70% of energy-intensive companies are moving investments out of Germany, driven by rising energy costs, CO₂ pricing, po...

In this episode of Supply Chain 360 , part of the ongoing BANI mini-series, we explore the fourth and final CORE pillar: Enablement - the force that turns strategy into motion. In a world that’s brittle, anxious, nonlinear, and incomprehensible, enablement is what transforms information into action. It’s not just about tools or training, it’s about trust, confidence, and culture. When people are e...

In this episode of Supply Chain 360 , part of our BANI mini-series, we unpack the third CORE pillar: Risk . In a world that’s brittle, anxious, nonlinear, and incomprehensible, traditional “risk management” as a checklist or insurance policy isn’t enough. Today’s disruptions, cyber events, trade shifts, API shortages, extreme weather, don’t arrive one at a time; they overlap, cascade, and amplify...

In this episode of Supply Chain 360 , part of the ongoing BANI mini-series, we explore the second CORE pillar: Orchestration — the art of turning complexity into coordination. Pharma supply chains are filled with hundreds of moving parts — suppliers, regulators, logistics partners, and manufacturers — all operating on their own timelines. True orchestration is about creating alignment along the en...

In this episode of Supply Chain 360 , part of the ongoing BANI mini-series, we dive into the first CORE pillar: Complexity . Pharma supply chains aren’t simple, linear systems, they’re intricate networks of suppliers, regulators, manufacturers, and logistics partners, all bound together by interdependence and risk. The more we’ve optimized for efficiency, the more brittle those networks have becom...

In this episode of Supply Chain 360 , we continue our BANI mini-series — exploring how to lead and build in a world that’s brittle, anxious, nonlinear, and incomprehensible. For years, resilience was the ultimate goal in supply-chain management. But in today’s constant state of disruption, bouncing back isn’t enough. It’s time to move toward viability — the ability to adapt, evolve, and stay relev...

This kickoff to my BANI mini‑series unpacks how brittle, anxious, non‑linear and incomprehensible dynamics are reshaping pharma supply chains. We discuss real‑world brittleness: a 7.4‑magnitude earthquake in Japan that halted chip production and ground Detroit’s auto assembly, and a software update that locked up millions of computers and grounded. We examine how U.S. tariffs on Chinese imports ha...

In this episode, I reflect on the growing trend of AI being used to cut jobs, often without a clear plan for reskilling or redeployment. Triggered by a recent New York Times article mentioning layoffs at companies like Microsoft and Recruit Holdings, I question whether we’re losing the human in the process. AI isn’t the problem. It’s how we choose to implement it that matters. Here is the link to...

Welcome to this special episode of my podcast, where I explore the critical aspects of Talent Management—not just as a process of developing leaders but as a balanced framework that equally emphasizes followership development. Using insights from various scholarly and professional sources, I aim to reshape how organizations think about managing their most vital asset: People.

Today's episode focuses on the role of AI in Pharmaceutical Manufacturing, specifically how it is powering personalized medicine. We will explore AI's impact today and what the future looks like by 2030, with technologies like digital twins driving efficiency and precision in drug development.

In this episode we will dive into how identified challenges in supply chain management become opportunities - or maybe not? Curious? Tune in and find out.

I'm excited to share my first episode of my podcast, where I dive into one of the hottest topics in the logistics and supply chain world—Generative AI! This groundbreaking technology is reshaping supply chain management, from demand forecasting to real-time logistics optimization. In this episode, you'll learn: How generative AI is revolutionizing inventory management Real-world applications drivi...